However, because a high concentration of AnxA1 could induce a proinflammatory response via FPR1 rather than FPR2, further study of the AnxA1-stimulated receptor type subsequent to the activated signaling pathway is necessary to determine the action of AnxA1 in NAFLD. The gene discussed is FPR2; the disease is metabolic dysfunction-associated steatotic liver disease.